Juciano Gasparotto

Juciano Gasparotto

Auto-generated profile, based on publicly available information

Juciano Gasparotto

Centro de Estudos em Estresse Oxidativo, Departamento de Bioquimica, Instituto de Ciencias Basicas da Saude, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2017 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
RBR C Bortolin
R C Bortolin
AVA R Vargas
A R Vargas
JGJ Gasparotto
J Gasparotto
PCP R Chaves
P R Chaves
CSCarlos Eduardo Schnorr
Carlos Eduardo Schnorr
JMJ C F Moreira
J C F Moreira
Background/Objectives: Obesity is a metabolic disorder that predisposes patients to numerous diseases and has become a major global public-health concern. Animal models of diet-induced obesity (DIO) are frequently used to study obesity, but which DIO model most accurately reflects the pathology of human obesity remains unclear. In this study, we designed a diet based on the human Western diet (WD) and compared it with the cafeteria diet (CAF) and high-fat diet (HFD) in order to evaluate which diet most closely mirrors human obesity. Methods: Wistar rats were fed four different diets (WD, CAF, HFD and a low-fat diet) for 18 weeks. Metabolic parameters and gut microbiota changes were then characterized. Results: Rats fed the four different diets exhibited completely different phenotypes, highlighting the importance of diet selection. This study also revealed that WD most effectively induced obesity and obesity-related disorders, and thus proved to be a robust model of human obesity. Moreover, WD-fed rats developed obesity and obesity-related comorbidities independent of major alterations in gut microbiota composition (dysbiosis), whereas CAF-fed rats developed the greatest dysbiosis independent of obesity. We also characterized gut microbiota after feeding on these four different diets and identified five genera that might be involved in the pathogenesis of obesity. Conclusions: These data suggest that diet, and not the obese state, was the major driving force behind gut microbiota changes. Moreover, the marked dysbiosis observed in CAF-fed rats might have resulted from the presence of several additives present in the CAF diet, or even a lack of essential vitamins and minerals. Based on our findings, we recommend the use of the prototypic WD (designed here) in DIO models. Conversely, CAF could be used to investigate the effects of excessive consumption of industrially produced and highly processed foods, which are characteristic of Western society.

1 January 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JGJuciano Gasparotto
Juciano Gasparotto
CSCarolina Saibro-Girardi
Carolina Saibro-Girardi
NSNauana Somensi
Nauana Somensi
CRCamila T. Ribeiro
Camila T. Ribeiro
JMJosé C. F. Moreira
José C. F. Moreira
DGDaniel Gelain
Daniel Gelain
Patients recovering from sepsis have higher rates of CNS morbidities associated with long-lasting impairment of cognitive functions, including neurodegenerative diseases. However, the molecular etiology of these sepsis-induced impairments is unclear. Here, we investigated the role of the receptor for advanced glycation end products (RAGE) in neuroinflammation, neurodegeneration-associated changes, and cognitive dysfunction arising after sepsis recovery. Adult Wistar rats underwent cecal ligation and perforation (CLP), and serum and brain (hippocampus and prefrontal cortex) samples were obtained at days 1, 15, and 30 after the CLP. We examined these samples for systemic and brain inflammation; amyloid-β peptide (Aβ) and Ser-202-phosphorylated tau (p-tauser202) levels; and RAGE, RAGE ligands, and RAGE intracellular signaling. Serum markers associated with the acute proinflammatory phase of sepsis (TNF-α, IL-1β, and IL-6) rapidly increased and then progressively decreased during the 30-day period post-CLP, concomitant with a progressive increase in RAGE ligands (S100B, Nϵ-[carboxymethyl]lysine, HSP70, and HMGB1). In the brain, levels of RAGE and Toll-like receptor 4, glial fibrillary acidic protein and neuronal nitric oxide synthase, and Aβ and p-tauser202 also increased during that time. Of note, intracerebral injection of RAGE antibody into the hippocampus at days 15, 17, and 19 post-CLP reduced Aβ and p-tauser202 accumulation, Akt/mTOR signaling, levels of ionized calcium-binding adapter molecule 1 and GFAP, and behavioral deficits associated with cognitive decline. These results indicate that brain RAGE is an essential factor in the pathogenesis of neurological disorders following acute systemic inflammation.

22 August 2017 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
NSNauana Somensi
Nauana Somensi
PBPedro Ozorio Brum
Pedro Ozorio Brum
VRVitor de Miranda Ramos
Vitor de Miranda Ramos
JGJuciano Gasparotto
Juciano Gasparotto
Alfeu Zanotto-FilhoAlfeu Zanotto-Filho
Alfeu Zanotto-Filho
DGDaniel Pens Gelain
Daniel Pens Gelain
Background/Aims: Heat shock protein 70 (HSP70) has been recently described with extracellular actions, where it is actively released in inflammatory conditions. Acting as DAMPs (damage associated molecular pattern), extracellular HSP70 (eHSP70) interacts with membrane receptors and activates inflammatory pathways. At this context, the receptor for advanced glycation endproducts (RAGE) emerges as a possible candidate for interaction with eHSP70. RAGE is a pattern-recognition receptor and its expression is increased in several diseases related to a chronic pro-inflammatory state. One of the main consequences of RAGE ligand-binding is the ERK1/2 (extracellular signal–regulated kinases)-dependent activation of NF-kB (nuclear factor kappa B), which leads to expression of TNF-α (tumor necrosis factor alpha) and other cytokines. The purpose of this work is to elucidate if eHSP70 is able to evoke RAGE-dependent signaling using A549 human lung cancer cells, which constitutively express RAGE. Methods: Immunoprecipitation and protein proximity assay were utilized to demonstrate the linkage between RAGE and eHSP70. To investigate RAGE relevance on cell response to eHSP70, siRNA was used to knockdown the receptor expression. Signaling pathways activation were evaluated by western blotting, gene reporter luciferase and real time quantitative PCR. Results: Protein eHSP70 shown to be interacting physically with the receptor RAGE in our cell model. Treatment with eHSP70 caused ERK1/2 activation and NF-κB transactivation impaired by RAGE knockdown. Moreover, the stimulation of pro-inflammatory cytokines expression by eHSP70 was inhibited in RAGE-silenced cells. Finally, conditioned medium of eHSP70-treated A549 cells caused differential effects in monocytes cytokine expression when A549 RAGE expression is inhibited. Conclusions: Our results evidence eHSP70 as a novel RAGE agonist capable of influence the cross-talk between cancer and immune system cells.

1 December 2018 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
JGJuciano Gasparotto
Juciano Gasparotto
PCPaloma Rodrigues Chaves
Paloma Rodrigues Chaves
KMKátia da Boit Martinello
Kátia da Boit Martinello
HRHelen Tais da Rosa-Siva
Helen Tais da Rosa-Siva
RBRafael Calixto Bortolin
Rafael Calixto Bortolin
JMJosé Claudio Fonseca Moreira
José Claudio Fonseca Moreira

1 October 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
TRThallita Kelly Rabelo
Thallita Kelly Rabelo
AGAdriana Gibara Guimarães
Adriana Gibara Guimarães
MOMarlange Almeida Oliveira
Marlange Almeida Oliveira
JGJuciano Gasparotto
Juciano Gasparotto
MSMairim Russo Serafini
Mairim Russo Serafini
DGDaniel Gelain
Daniel Gelain

18 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JGJuciano Gasparotto
Juciano Gasparotto
CRCamila Tiefensee Ribeiro
Camila Tiefensee Ribeiro
RBRafael Calixto Bortolin
Rafael Calixto Bortolin
NSNauana Somensi
Nauana Somensi
TRThallita Kelly Rabelo
Thallita Kelly Rabelo
DGDaniel Pens Gelain
Daniel Pens Gelain
The receptor for advanced glycation endproducts (RAGE) is a pattern-recognition receptor associated with inflammation in most cell types. RAGE up-regulates the expression of proinflammatory mediators and its own expression via activation of NF-kB. Recent works have proposed a role for RAGE in Parkinson’s disease (PD). In this study, we used the multimodal blocker of RAGE FPS-ZM1, which has become available recently, to selectively inhibit RAGE in the substantia nigra (SN) of rats intracranially injected with 6-hydroxydopamine (6-OHDA). FPS-ZM1 (40 μg per rat), injected concomitantly with 6-OHDA (10 μg per rat) into the SN, inhibited the increase in RAGE, activation of ERK1/2, Src and nuclear translocation of NF-kB p65 subunit in the SN. RAGE inhibition blocked glial fibrillary acidic protein and Iba-1 upregulation as well as associated astrocyte and microglia activation. Circulating cytokines in serum and CSF were also decreased by FPS-ZM1 injection. The loss of tyrosine hydroxylase and NeuN-positive neurons was significantly inhibited by RAGE blocking. Finally, FPS-ZM1 attenuated locomotory and exploratory deficits induced by 6-OHDA. Our results demonstrate that RAGE is an essential component in the neuroinflammation and dopaminergic denervation induced by 6-OHDA in the SN. Selective inhibition of RAGE may offer perspectives for therapeutic approaches.